HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort.
Saved in:
| Title: | HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort. |
|---|---|
| Authors: | Ateş Ü; Division of Allergy and Immunology, Department of Internal Medicine, Ege University Faculty of Medicine, 35100 Izmir, Türkiye., Keskinkılıç M; Department of Medical Oncology, İzmir Demokrasi University Buca Seyfi Demirsoy Training and Research Hospital, 35390 Izmir, Türkiye., Binnaz Demirkan HM; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Dokuz Eylül University, 35340 Izmir, Türkiye. |
| Source: | Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2026 Jun 30; Vol. 62 (7). Date of Electronic Publication: 2026 Jun 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
